Zobrazeno 1 - 10
of 15 107
pro vyhledávání: '"Jové, J."'
Autor:
Ciruela, P., Izquierdo, C., Broner, S., Hernández, S., Jané, M., Muñoz-Almagro, C., Esteva, C., de Sevilla, M.F., Henares, D., Pallarés, R., Ardanuy, C., Grau, I., Marco, F., Margall, N., González-Cuevas, A., Díaz, A., Martin, M.T., Llaberia, J., Curriu, M., Gallés, C., Capdevila, E., Gassiot, P., Martínez-Zurita, M., Martí, C., Morta, M., Sauca, G., Gassós, A., Sanfeliu, E., Ballester, F., Pujol, I., Olsina, M., Raga, X., Gómez-Bertomeu, F., Pérez-Moreno, M.O., Vilamala, A., Navarro, M., Ribelles, M., Garcia, M., Padilla, E., Prim, N., Fontanals, D., Sanfeliu, I., Benitez, M.A., Jou, E., Sanjosé, C., Giménez, M., Quesada, M.D., de la Fuente, J.C., Calderon, A., Ayala, P.J., Vega, L., Pérez-Jové, J., Blanco, A., Balado, C., Valle, I., Bastida, M.T., Gonzalez-Moreno, O., Ubanell, A., Fenoll, A., Yuste, J., Ciruela, Pilar, Broner, Sonia, Izquierdo, Conchita, Pallarés, Roman, Muñoz-Almagro, Carmen, Hernández, Sergi, Grau, Imma, Domínguez, Angela, Jané, Mireia
Publikováno v:
In International Journal of Infectious Diseases September 2019 86:122-130
Autor:
Hurley E; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Geisler BP; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lupattelli A; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute, Miguel Servet University Hospital, Saragossa, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion, Research Network on Health Services in Chronic Diseases, Institute of Health Carlos III, Madrid, Spain., Lassalle R; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Jové J; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Bernard MA; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sakr D; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sanfélix-Gimeno G; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sánchez-Saez F; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Rodríguez-Bernal CL; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sabaté M; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Ballarín E; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Aguilera C; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Jordan S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Thayer D; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Farr I; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Ahmed S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Bartolini C; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Limoncella G; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Paoletti O; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Maglanoc LA; IT Department, Data Management, University of Oslo, Oslo, Norway., Dudukina E; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Alsina E; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Vaz TA; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Riera-Arnau J; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain.; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Sturkenboom MCJM; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Nordeng HME; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 May; Vol. 80 (5), pp. 707-716. Date of Electronic Publication: 2024 Feb 12.
Autor:
Gouverneur A; Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD; CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, 33000, Bordeaux, France., Favary C; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000, Bordeaux, France., Jové J; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000, Bordeaux, France., Rouyer M; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000, Bordeaux, France., Bignon E; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000, Bordeaux, France., Salvo F; Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD; CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, 33000, Bordeaux, France., Tchalla A; Université de Limoges, Institut OMEGA HEALTH, Laboratoire VieSanté - UR 24134 (Vieillissement, Fragilité, Prévention, e-Santé); CHU de Limoges, Pôle HU de gérontologie clinique, Service de médecine gériatrique, 87042, Limoges, France., Paillaud E; Université de Paris Cité, Paris Cancer Institute CARPEM; Hôpital Européen Georges Pompidou, APHP, Service de gériatrie, 75015, Paris, France., Aparicio T; Université de Paris; Hôpital Saint-Louis, APHP, Service de gastroentérologie, 75010, Paris, France., Noize P; Univ. Bordeaux, INSERM, BPH, U1219, Team AHeaD; CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, 33000, Bordeaux, France. pernelle.noize@u-bordeaux.fr.
Publikováno v:
Targeted oncology [Target Oncol] 2023 Sep; Vol. 18 (5), pp. 717-726. Date of Electronic Publication: 2023 Sep 08.
Autor:
Zamora V; Health Services Research Group, Hospital del Mar Research Institute, Barcelona Biomedical Research Park, Office 144. Doctor Aiguader, 88, 08003, Barcelona, Spain.; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain.; CIBER en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain., Garin O; Health Services Research Group, Hospital del Mar Research Institute, Barcelona Biomedical Research Park, Office 144. Doctor Aiguader, 88, 08003, Barcelona, Spain. ogarin@imim.es.; CIBER en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain. ogarin@imim.es.; Universitat Pompeu Fabra, Barcelona, Spain. ogarin@imim.es., Suárez JF; Urology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Jové J; Radiation Oncology Department, Institut Català d'Oncologia, Badalona, Spain., Castells M; Urology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Ferrer F; Radiation Oncology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain., Gutiérrez C; Radiation Oncology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain., Guedea F; Radiation Oncology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain., Boladeras A; Radiation Oncology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain., Fumadó L; Urology Department, Hospital del Mar, Barcelona, Spain., Roselló A; Radiation Oncology Department, Institut Català d'Oncologia, Girona, Spain., Pastor J; Radiation Oncology Department, ASCIRES GRUPO BIOMÉDICO, Valencia, Spain., Samper P; Radiation Oncology Department, Hospital Universitario Rey Juan Carlos, Móstoles, Spain., Pont À; Health Services Research Group, Hospital del Mar Research Institute, Barcelona Biomedical Research Park, Office 144. Doctor Aiguader, 88, 08003, Barcelona, Spain.; CIBER en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain., Ferrer M; Health Services Research Group, Hospital del Mar Research Institute, Barcelona Biomedical Research Park, Office 144. Doctor Aiguader, 88, 08003, Barcelona, Spain. mferrer@imim.es.; CIBER en Epidemiología y Salud Pública, CIBERESP, Madrid, Spain. mferrer@imim.es.; Universitat Pompeu Fabra, Barcelona, Spain. mferrer@imim.es.
Publikováno v:
World journal of urology [World J Urol] 2023 Dec; Vol. 41 (12), pp. 3511-3518. Date of Electronic Publication: 2023 Nov 10.
Autor:
Bonet M; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. Mabonet.lleida.ics@gencat.cat., González D; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Baquedano JE; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., García E; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Altabas M; Radiation Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Casas F; Radiation Oncology, Hospital Clínic, ICMHO (Institut Clínic de Malalties Hematològiques i Oncològiques), Barcelona, Spain., Feltes N; Radiation Oncology, Consorci Sanitari de Terrassa, Hospital de Terrassa, Terrassa, Spain., Ferrer F; Radiation Oncology, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain., Foro P; Radiation Oncology, Parc de Salut Mar, Barcelona, Spain., Fuentes R; Radiation Oncology, Institut Català d'Oncologia, Hospital Josep Trueta, Barcelona, Spain., Galdeano M; Radiation Oncology, Consorci Sanitari de Terrassa, Fundació Althaia, Manresa, Spain., Gomez D; Radiation Oncology, Hospital Sant Joan de Reus, Reus, Tarragona, Spain., Henriquez I; Radiation Oncology, Hospital Sant Joan de Reus, Reus, Tarragona, Spain., Jové J; Radiation Oncology, Institut Català d'Oncologia, Hospital Can Ruti, Badalona, Spain., Lozano J; Radiation Oncology, Consorci Sanitari de Terrassa, Hospital de Terrassa, Terrassa, Spain., Maldonado X; Radiation Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Mases J; Radiation Oncology, Hospital Clínic, ICMHO (Institut Clínic de Malalties Hematològiques i Oncològiques), Barcelona, Spain., Membrive I; Radiation Oncology, Parc de Salut Mar, Barcelona, Spain., Paredes S; Radiation Oncology, Consorci Sanitari de Terrassa, Fundació Althaia, Manresa, Spain., Roselló À; Radiation Oncology, Institut Català d'Oncologia, Hospital Josep Trueta, Barcelona, Spain., Sancho G; Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Mira M; Radiation Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Apr; Vol. 25 (4), pp. 1017-1023. Date of Electronic Publication: 2022 Nov 27.
Autor:
Thurin NH; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France. Electronic address: nicolas.thurin@u-bordeaux.fr., Jové J; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France., Lassalle R; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France., Rouyer M; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France., Lamarque S; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France., Bosco-Levy P; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France., Segalas C; University of Paris Cité, Centre of Epidemiology and Statistics (CRESS) INSERM, Paris, France., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Blin P; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France., Droz-Perroteau C; University of Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, Bordeaux, France.
Publikováno v:
Journal of clinical epidemiology [J Clin Epidemiol] 2023 Mar; Vol. 155, pp. 31-38. Date of Electronic Publication: 2023 Jan 16.
Autor:
Baulain R; École nationale de la statistique et de l'administration économique Paris (ENSAE) Institut Polytechnique Paris Palaiseau France.; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Jové J; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Sakr D; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Gross-Goupil M; Medical Oncology, Hôpital Saint André CHU de Bordeaux Bordeaux France., Rouyer M; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Puel M; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Blin P; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Droz-Perroteau C; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Lassalle R; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France., Thurin NH; Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi Bordeaux France.
Publikováno v:
Cancer innovation [Cancer Innov] 2023 Jan 17; Vol. 2 (1), pp. 52-64. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2023).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thurin NH; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Rouyer M; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Jové J; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Gross-Goupil M; Medical Oncology Department, Hôpital Saint-André, Bordeaux University Hospital, Bordeaux, France., Haaser T; Radiotherapy Department, Hôpital Haut Lévêque, Bordeaux University Hospital, Pessac, France., Rébillard X; Urology Department, Clinique Beau Soleil, Montpellier, France., Soulié M; Urology Department, Hôpital Rangueil, Toulouse University Hospital, Toulouse, France., de Pouvourville G; ESSEC, Cergy-Pontoise, France., Capone C; Janssen EMEA, Beerse, Belgium., Bazil ML; Janssen-Cilag, Issy-les-Moulineaux, France., Messaoudi F; Janssen-Cilag, Issy-les-Moulineaux, France., Lamarque S; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Bignon E; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Droz-Perroteau C; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Moore N; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France., Blin P; INSERM CIC-P 1401, Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France.
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2022 Sep; Vol. 15 (9), pp. 1139-1145. Date of Electronic Publication: 2022 Aug 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.